Jul 6, 2022, 09:21 AM by

With only a few antibiotics in clinical development, new technologies, especially ones that do not develop antimicrobial resistance, are needed to treat healthcare-associated infections. An innovation from UCL in London and developed by Canadian life sciences company, Ondine Biomedical, uses photodisinfection to kill infection-causing pathogens, including viruses, bacteria, and fungi.

Jul 5, 2022, 09:43 AM by

DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400 Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose

Jul 5, 2022, 09:42 AM by

Jul 5, 2022, 09:40 AM by

Jul 5, 2022, 09:37 AM by

The global 3D bioprinting market is segmented based on technology, material, application and geography. Based on technology, the market is categorized into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting and microextrusion 3D bioprinting.

Jul 5, 2022, 09:36 AM by

Jul 5, 2022, 09:35 AM by

Jul 5, 2022, 09:35 AM by

Jul 5, 2022, 09:35 AM by

Jul 5, 2022, 09:34 AM by

Jul 5, 2022, 09:33 AM by

Jul 5, 2022, 01:00 AM by User Not Found

Bio-IT World | At Stanford University, precisely targeted drug delivery is in view using wireless micromachines that can navigate the rugged terrain of the human body, including the slippery surface of organs and vessels where blood flow may be impeded by hypertension and arterial plaques. The all-in-one amphibious robots’ locomotion is controlled by the strength and orientation of a three-dimensional magnetic field.

Jul 1, 2022, 09:13 AM by

Jul 1, 2022, 09:11 AM by

BOC Sciences announced impurity isolation and identification services using traditional and innovative impurity techniques.

Jun 30, 2022, 09:18 AM by

Jun 30, 2022, 09:17 AM by

MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease management through predictive analytics, today announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease and increased risk of complications such as chronic kidney disease. The partnership will provide access to data from patient populations in Asia that have historically been underrepresented in chronic metabolic disease studies.

Jun 30, 2022, 09:17 AM by

Jun 30, 2022, 09:17 AM by

#1 AI clinical analytics platform company Saama Technologies welcomes global life sciences industry expert Vivek Sharma as new CEO

Jun 30, 2022, 09:15 AM by

Leadership Team Expansion Follows Year of Accelerated Growth

Jun 30, 2022, 09:14 AM by

PHASTAR Names Chris Schoonmaker as Chief Operations Officer  London, UK and Durham, NC - June 29, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Chris Schoonmaker has joined the company as Chief Operations Officer. Chris will direct PHASTAR’s operational strategy with a key focus on ensuring quality deliverables and providing a positive customer experience.